Botulinum toxin (BNT) market is expected to reach a value of USD 7.3 billion by 2025

The constant introduction of innovative products for enhancement of aesthetic appeal supporting minimally invasive aesthetic treatments is the prime factor driving the growth of the market.

In addition, rapid growth of the sector is attributed to the rising demand for minimally invasive or non-invasive procedures. These procedures provide advantages such as small incision, shorter hospital stay and rapid wound healing, and hence lead to larger acceptance and demand. In addition, availability of wide variety of minimally invasive or non-invasive treatment options is pushing the global botulinum toxin market towards growth.

Also, the successful completion of research projects is expected to expand the applications of presently approved products. Companies are trying to widen the application of botulinum toxin in therapeutic area through various research activities. For instance, Botox by Allergan received the U.S. FDA approval for the treatment of strabismus (crossed eyes) and blepharospasm associated with dystonia in 1989. Furthermore, in 2004, Botox was approved by the U.S. FDA for hyperidrosis, cervical dystonia, upper limb spasticity, chronic migraine and urinary incontinence in 2009, 2010 and 2011 respectively. Hence, these factors all together will aid in boosting the growth of BNT sales during the forecast period.

View summary of this report, Click Here 

Further Key Findings from the Study Suggest:

• The rapid adoption of minimally invasive treatment is augmenting the growth of neurotoxins market.
• The botulinum toxin type A segment accounted for the largest share in 2015 and is also anticipated to be the fastest growing segment during the forecast period
• In 2015, North America dominated the global space with the largest revenue share owing to high demand for minimally invasive or non-invasive aesthetic treatments
• Asia Pacific is expected to emerge as the fastest growing region during the forecast period, mainly due to growing social awareness regarding anti-wrinkle procedures in India, China, and Japan
• Major players competing in this market include but are not limited to Allergan, Inc.; Ipsen Group; Merz GmbH and Co. KGaA, Medytox,Inc.; US Worldmed, LLC; Lanzhou Institute of Biological Products. Co.Ltd. and Revance Therapeutics, Inc.

Click Here For Access Full Report : https://goo.gl/ungiAi

Hearing amplifiers market size is expected to reach USD 78.2 million by 2022

Global hearing amplifiers market is expected to reach USD 78.2 million by 2022, according to a new study by Grand View Research Inc. Growing prevalence of deafness and hearing disorders and the increasing cost of hearing aids are expected to drive the hearing amplifiers market over the forecast period. Hearing amplifiers are relatively cheaper products and therefore, are more preferred in patients with manageable deafness severities. For instance, the ASP of hearing amplifier amounts to USD 200, as opposed to hearing aids priced at approximately USD 450 to 1,000. Rising R&D investments aimed at new product development in congruence with the changing consumer dynamics is expected to significantly contribute towards expedited market growth.

To request a sample copy or view summary of this report, click the link below: 
http://www.grandviewresearch.com/industry-analysis/hearing-amplifiers-market

Further key findings from the study suggest:

• On the ear hearing amplifiers were the largest product segment of the market in 2014. The fact that, on the ear hearing amplifiers are comfortable to use, render high connectivity and are user-friendly is expected to drive segment growth over the forecast period.
• In the ear hearing amplifiers are identified as the most lucrative product segment of the market. In the ear hearing amplifiers allow clear perception of surrounding voice as it blocks the entire ear cavity and prohibit the passage of the user’s own voice and this is expected to serve the segment as a driver. Moreover, these devices score high on the consumer preference matrix owing to their aesthetic appeal.
• Asia Pacific is expected to spearhead future market growth. The increasing prevalence of deafness especially in the geriatric population and growing retail healthcare industry in emerging countries such as India and China are some factors attributing to region’s rapid market growth.
• China is expected to witness the fastest growth over the forecast period. As per the National Bureau of Statistics of China, approximately 185 million are over the age of 60. According to the United Nations study of 2007, by 2025, 64 elderly for every 100 workers is the estimated ratio in China. In 2003, as per a study of the United Nations Children's Fund (UNICEF), approximately 10% of the population had hearing loss. The Second China National Survey on Disability by the China Disabled Persons' Federation (CDPF) identified 20.04 million people as “hearing impaired”. Growing population in China and introduction of technologically advanced devices are expected to drive the market over the forecast period.
• Key players of the hearing amplifiers market include Resound, SoundHawk, Shenzhen LA Lighting Company Limited, Austar Hearing Science And Technology (Xiamen) Co., Ltd., Ziphearing and Huizhou Jinghao Electronics Co. Ltd.  

To get full details at:  

http://www.grandviewresearch.com/industry-analysis/hearing-amplifiers-market

Human Papillomavirus (HPV) testing and Pap test market size are expected to reach USD 5.6 billion by 2024

The global Human Papillomavirus (HPV) testing and Pap test market are expected to reach USD 5.6 billion by 2024, according to a new report by Grand View Research Inc.The market is majorly driven by the increasing number of cervical cancer cases, government initiatives, and the heightened awareness amongst women about cervical cancer. For instance, the CDC advocates cervical cancer screening tests for women above the age of 30 as it was found that the cervical cancers are rare in the age group, 20-30 years (2 in 100,000) as compared to the older age groups (16 in 100,000). 

HPV Testing and Pap Test Market: 

In addition to carrying out awareness campaigns, the government and key industrial players are providing funding to universities for the development of enhanced technologies to facilitate effective screening, which would mitigate the incidence of late-stage cervical cancer. In this direction,in April 2014, the FDA approved the use of the HPV DNA test, also referred to as the Cobas HPV test (Roche Molecular Systems), as a primary screening test. 

A study conducted by the scientists of Hologic, Inc. and University of Pittsburgh Medical Center hasshownthe importance of combined testing (HPV and Pap) stating that the Paptest identifies cellular abnormalities and the HPV test detects suspicious viruses, hence improving the efficiency and providing the best results that are cost-effective and convenient to the patients. 

view summary of this report, click the link below: 

http://www.grandviewresearch.com/industry-analysis/hpv-testing-pap-test-market

Further key findings from the report suggest:

• The cervical cancer screening segment dominated the market in 2015 owing to the introduction of advanced technologies for the screening and detection of cervical cancer. For instance, in May 2016,Hologic Inc. determined that HPV and Pap co-testing was the most effective in the screening of cervical cancer.
• The laboratories segment dominated the HAV and Pap test market in 2015 owing to the increased performance in the diagnosis of cervical cancer cases. As per the CDC statistics, approximately 21.7 million tests were performed in the U.S.; hence,the hospitalssegmentis expected to witnessa rapid growthin the coming years due to the increasing number of diagnostic tests performed in-house and also the availability of advanced technologies.
• In 2015, North America held the largest share in terms of revenue owing to the continual introduction ofinnovated technologies to improve patient care and diagnosis. In addition, the high number of positive cases being detected,along with the rising death toll (i.e., 2.6 in 1,00,000), has compelled the government to conduct awareness programmes about the early diagnosis and treatment of cervical cancer, which is a key factor for the large market share.
• In April 2014, the FDA approved the use of the HPV DNA test, also referred to as the Cobas HPV test. Roche introduced a test that detectsthe DNAsequence of cancer-causing high-risk HPVs. It provides information regardingpatients’ risk of developing cervical cancer. The Cobas HPV test is used to specifically identify HPV 16 and HPV 18as well as12 other high-risk HPVs from the cervical cell sample in women older than 25 years of age.
• AsiaPacific is expected to grow at a high CAGR in the coming years. As per the cancer council, 61% of the Australian women are screened for cervical cancer every two years, out of which around 26% who have been detected throughthe normal Pap test undergo an early re-screening more often than the recommended two years of interval.
• Some key players in the market are QiagenN. V., Hologic, Inc., Roche Holding AG, Abbott Laboratories, and Becton, Dickinson and Company.These market players are in the process of introducing tests to change the traditional methods of individual HPV and Pap tests and introducenewer techniques or devices to improve the efficiency and convenience.
• For instance, in February 2016, Quest acquiredClinical Laboratory Partner’s outreach laboratory service business. This acquisition is expected to provide the patients a broader service network with better quality, affordability, and convenience. 

Reference Links: 

http://www.grandviewresearch.com/industry-analysis/hpv-testing-pap-test-market

Healthcare Analytics Market Revenue To Near $42.8 Billion By 2024:Grand View Research, Inc.

The global healthcare analytics (HA) market is expected to reach USD 42.8 billion by 2024, according to a new report by Grand View Research, Inc. Efforts to reduce the spiraling healthcare costs is facilitating the usage of the healthcare analytics. Additionally, the benefits of HA include the improvement of patient access to customized care, the furthering of transparent operations to enable better public oversight, and innovation in patient care delivery and services.

                                      Predictive Analytics market estimates and trends

Furthermore, analytics play a major part in striving to ameliorate the health economic efficiency. For instance, l’Assurance Maladie in France employed analytics to assess the clinical safety of the class of cholesterol-lowering drugs, statins, which have been implicated in causing severe side-effects, and the derived results were used to introduce evidence-based performance measures to address the cracks in the operational system.

View summary of this report, click the link below: 

http://www.grandviewresearch.com/industry-analysis/healthcare-analytics-market

Further key findings from the study suggest:

• Descriptive analytics held a significant share in 2015 owing to its applications in process optimization in organizations. On the other hand, predictive analytics is anticipated to grow at a lucrative rate over the forecast period mainly due to its wide applicability in medical systems, such as fraud prevention, disease prevalence forecasts, and risk assessment.

• The services category dominated the component segment in 2015. Outsourcing of these big data services contributed towards their growth in leading to the high volume of services rendered. Moreover, the outsourcing of services helps in cutting costs associated with infrastructure requirements and in addition, avoids the requirement of skilled individuals to perform the same task.

• The hardware systems category dominated the component segment, high-cost of the hardware, such as the use of computer systems and internet servers contributed to its growth.

• On-premise delivered analytic services dominated the delivery mode category with around 54.0% share in 2015. However, the cloud-based delivery mode segment is anticipated to grow at a profitable rate over the forecast period. The benefits of the cloud system, which include remote data entry and real-time data entry features are expected to result in the growth of this segment.

• The applications of the healthcare big data include financial applications, operational & administrative applications, and clinical applications. Operational and administrative applications governed the applications segment and held a remunerative share in the year, 2015.

• The demand for financial applications is anticipated to boost over the forecast period. These applications include payment and claim settlements and fraud prevention and risk analysis. Various initiatives undertaken by the government, such as the Fraud Prevention System (FPS) from the CMS is promoting its adoption.

• The end-users of HA include payers, providers, and others. Payers held a significant market share in 2015 and the providers are anticipated to grow at a lucrative rate. The usage of these services by providers is for population health management, quality improvement, and personalized care.

• North America captured a significant share in the global market. Advanced healthcare infrastructure in this region and the growing per capita healthcare expenditure supported the greater consumption of these services.

• The Asia Pacific region is expected to witness gainful growth attributable to the untapped opportunities in the countries including India and China.

• Some key players operating in the healthcare analytics market include IBM Corporation, Oracle Corporation, SAS, Cerner Corporation, Allscripts Healthcare Solutions, Inc., Optum Health, Inc., and Verisk Analytics, Inc. The notable initiatives in the industry include new product launches, collaboration with government bodies, and investments directed towards R&D efforts.

• For instance, in December 2015 Truven Health Analytics, Inc. and Philips Electronics N.V. integrated Truven Health Micromedex Solutions in the management platform, the Tasy System. This integrated platform is anticipated to facilitate fast and easy access to a wealth of evidence-based medical information present in the drug interaction repositories of Micromedex Solutions.

Grand View Research has segmented the global healthcare analytics market on the basis of products, end-use, and region:

Global Healthcare Analytics Market by Type, 2013 - 2024 (USD Million)

• Descriptive Analytics

• Predictive Analytics

• Prescriptive Analytics

Global Healthcare Analytics Market by Component, 2013 - 2024 (USD Million)

• Software

• Hardware

• Services

Global Healthcare Analytics Market, by Delivery Mode, 2013 - 2024 (USD Million)

• On-premise

• Web-based

• Cloud-based

Global Healthcare Analytics Market, by Application, 2013 - 2024 (USD Million)

• Clinical

• Financial

• Operational and Administrative

Global Healthcare Analytics Market, by End-use, 2013 - 2024 (USD Million)

• Healthcare Payers

• Healthcare Providers

• Others

To get free sample request at:

http://www.grandviewresearch.com/industry-analysis/healthcare-analytics-market/request